Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eltrombopag for platelet recovery in adult patients with dengue fever
IRCT20240208060941N3Phase 3Completed
- Sponsor
- Pak Emirates Military Hospital
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of eltrombopag in dengue fever (2 arms), sponsored by Pak Emirates Military Hospital. Primary endpoints: Platelet recovery time and Incidence of bleeding complications. Started Oct 2024; status: completed.
02
Drugs
eltrombopag
03
Conditions
dengue fever
Beyond the preview
Go deeper on IRCT20240208060941N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240208060941N3.